Zeke Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.66M | Buy |
3,016
+988
| +49% | +$544K | 0.11% | 91 |
|
|
2022
Q3 | $1.03M | Sell |
2,028
-29
| -1% | -$14.7K | 0.07% | 117 |
|
|
2022
Q2 | $1.12M | Buy |
2,057
+40
| +2% | +$21.7K | 0.07% | 119 |
|
|
2022
Q1 | $1.19M | Buy |
+2,017
| New | +$1.19M | 0.06% | 126 |
|
|
2020
Q1 | – | Sell |
-4,986
| Closed | -$1.62M | – | 482 |
|
|
2019
Q4 | $1.62M | Hold |
4,986
| – | – | 0.13% | 129 |
|
|
2019
Q3 | $1.45M | Sell |
4,986
-21
| -0.4% | -$6.12K | 0.13% | 135 |
|
|
2019
Q2 | $1.47M | Sell |
5,007
-307
| -6% | -$90.1K | 0.14% | 133 |
|
|
2019
Q1 | $1.46M | Sell |
5,314
-1,788
| -25% | -$490K | 0.14% | 133 |
|
|
2018
Q4 | $1.59M | Sell |
7,102
-2,895
| -29% | -$648K | 0.15% | 114 |
|
|
2018
Q3 | $2.44M | Buy |
9,997
+33
| +0.3% | +$8.05K | 0.2% | 82 |
|
|
2018
Q2 | $2.06M | Hold |
9,964
| – | – | 0.19% | 88 |
|
|
2018
Q1 | $2.06M | Buy |
9,964
+19
| +0.2% | +$3.92K | 0.19% | 96 |
|
|
2017
Q4 | $1.89M | Buy |
9,945
+3,133
| +46% | +$595K | 0.2% | 83 |
|
|
2017
Q3 | $1.29M | Buy |
6,812
+3,324
| +95% | +$629K | 0.18% | 98 |
|
|
2017
Q2 | $609K | Buy |
3,488
+942
| +37% | +$164K | 0.12% | 111 |
|
|
2017
Q1 | $391K | Buy |
2,546
+545
| +27% | +$83.7K | 0.08% | 153 |
|
|
2016
Q4 | $282K | Buy |
+2,001
| New | +$282K | 0.08% | 142 |
|